Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

NCT00126815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-02-24

No results posted yet for this study

Summary

Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Conditions

Sponsors & Collaborators

  • Cross Cancer Institute

    collaborator OTHER
  • AHS Cancer Control Alberta

    lead OTHER

Principal Investigators

  • Matthew Parliament, MD · AHS Cancer Control Alberta

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2008-03-31
Completion
2008-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126815 on ClinicalTrials.gov